- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02786225
Collaboration for Antepartum Risk Evaluation (CARE)
Interprofessional Perinatal Consults to Improve Communication Quality, Satisfaction, and Team Cohesion: A Randomized Trial of the Collaboration for Antepartum Risk Evaluation (CARE) Model
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Perinatal outcomes in the United States rank below many other developed countries. National organizations, such as the American College of Obstetricians and Gynecologists, have called for women to utilize the level and provider of maternity services that meet their personal and medical needs. This leveled approach to care requires consultation and collaboration among providers to ensure women receive appropriate services. While national and international organizations have called for team-based maternity care, current models can fragment services, increasing the risk of communication errors. Women can feel disenfranchised by models that do not meet their needs and opt out of beneficial services altogether.
Currently, there is not evidence on effective interdisciplinary models of maternity care. The Collaboration for Antepartum Risk Evaluation (CARE) study will use a randomized design to systematically test the effect of interdisciplinary consults on women and providers. The two aims of the study are: (1) evaluate the effect of collaborative vs individual consults on participant outcomes including communication quality (using the Communication Assessment Tool, team version), maternal satisfaction (using a modified Satisfaction with Prenatal Care measure), semi-structured interviews, adherence to the developed plan of care, and perinatal outcomes; (2) evaluate the effect of the CARE clinic on providers using the Communication Assessment Tool- team version, the Agency for Healthcare Research and Quality (AHRQ) Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS) questionnaire, and semi-structured interviews.
The CARE study will provide valuable information on effective models for patient-centered maternity care. The AHRQ K08 will allow Dr. Philippi to implement the CARE study and facilitate her growth into a national leader in midwifery and health services research.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Tennessee
-
Nashville, Tennessee, Verenigde Staten, 37240
- Vanderbilt School of Nursing
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Adult pregnant women receiving prenatal care at the VUSN Nurse-Midwifery Faculty Practice.
- Gestational age of pregnancy 4-40 weeks
- Needs a consultation with perinatologist for one of the following reasons:
Prior pregnancy with congenital abnormality History of fetal demise >20 weeks History of preterm labor in previous pregnancy Current maternal drug or alcohol abuse Controlled maternal condition (e.g. thyroid disorder) Mild abnormality of fetus or placenta on ultrasound Idiopathic thrombocytopenia in pregnancy
- Can attend the collaborative care clinic
Exclusion Criteria:
- Unable to give consent for research participation - including age < 18 or impaired mental function
- Urgent medical condition requiring immediate assessment including: ectopic pregnancy or vaginal bleeding
- Medical conditions outside of scope of VUSN midwifery guidelines including:
Chronic maternal conditions requiring specialist involvement including: HIV, epilepsy, uncontrolled asthma, and liver, renal, cardiac disease.
Multiple gestation > 2 previous cesarean births Rh isoimmunization Incompetent cervix Major fetal or placenta abnormalities
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Collaborative Care
Intervention Group: Women (n=118) will be seen one time, simultaneously by a Vanderbilt University Medical Center (VUMC) perinatologist and a Vanderbilt University School of Nursing (VUSN) nurse-midwife (the CARE visit).
During the CARE visit, the nurse-midwife and perinatologist will complete the CARE checklist The checklist will be signed by the woman and providers and scanned into the medical record.
Following the CARE visit, women will return to midwifery care or be referred to perinatology depending on their needs, remaining in the study.
Women returning to the midwifery practice will see a primary midwife for the remainder of care.
|
Intervention Group: Women (n=118) will be seen one time, simultaneously by a VUMC perinatologist and a VUSN nurse-midwife (the CARE visit).
During the CARE visit, the nurse-midwife and perinatologist will complete the CARE checklist The checklist will be signed by the woman and providers and scanned into the medical record.
Following the CARE visit, women will return to midwifery care or be referred to perinatology depending on their needs, remaining in the study.
Women returning to the midwifery practice will see a primary midwife for the remainder of care.
|
|
Actieve vergelijker: Comparison Care- Usual Care + primary midwife
Comparison Group: Usual care enhanced with primary midwife.
Women in the comparison group (n=118) will receive the standard individual consult visit with a perinatologist and then, if they return to midwifery care, have one consistent midwife (primary midwife) for the majority of remaining prenatal care.
|
Comparison Group: Usual care enhanced with primary midwife.
Women in the comparison group (n=118) will receive the standard individual consult visit with a perinatologist and then, if they return to midwifery care, have one consistent midwife (primary midwife) for the majority of remaining prenatal care.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Communication Assessment Tool (CAT)-Team survey
Tijdsspanne: 2 weeks after intervention/comparison visit
|
The CAT, developed by Makoul et al., assesses views of provider communication via 14 Likert responses ranging from 1= 'poor' to 5= 'excellent.
|
2 weeks after intervention/comparison visit
|
|
Satisfaction with Prenatal Care (SPC) scale
Tijdsspanne: 2 weeks after intervention/comparison visit
|
The SPC scale assesses patient satisfaction with prenatal care
|
2 weeks after intervention/comparison visit
|
|
Communication Assessment Tool (CAT)-Team survey - following birth
Tijdsspanne: Within 2 weeks after patient gives birth
|
The CAT, developed by Makoul et al., assesses views of provider communication via 14 Likert responses ranging from 1= 'poor' to 5= 'excellent.
|
Within 2 weeks after patient gives birth
|
|
Satisfaction with Prenatal Care (SPC) scale - following birth
Tijdsspanne: Within 2 weeks after patient gives birth
|
The SPC scale assesses patient satisfaction with prenatal care
|
Within 2 weeks after patient gives birth
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Smoking at 1st prenatal visit
Tijdsspanne: 1 week after the patient gives birth
|
1 week after the patient gives birth
|
|
|
For smokers, number of cigarettes per day
Tijdsspanne: 1 week after the patient gives birth
|
Number of cigarettes per day
|
1 week after the patient gives birth
|
|
Location of birth
Tijdsspanne: 1 week after patient gives birth
|
Location where the mother gave birth - Vanderbilt / Other hospital, Birth center, Home, En Route
|
1 week after patient gives birth
|
|
Provider at admission to labor and delivery
Tijdsspanne: 1 week after patient gives birth
|
Medical care provider at the time of admission in labor
|
1 week after patient gives birth
|
|
Patient & provider adherence to checklist plan
Tijdsspanne: 1 week after patient gives birth
|
Congruence between the anticipated plan of care at the time of the intervention/comparison visit and what occurred at the time of birth
|
1 week after patient gives birth
|
|
Gestational age at birth
Tijdsspanne: 1 week after patient gives birth
|
the gestational age of the baby at the time of birth - in weeks+days
|
1 week after patient gives birth
|
|
Infant birth weight
Tijdsspanne: 1 week after patient gives birth
|
Infant birth weight in grams as collected within 4 hours of birth
|
1 week after patient gives birth
|
|
Mode of birth
Tijdsspanne: 1 week after patient gives birth
|
Number of women giving birth via 1 of 4 methods: vaginal/assisted vaginal/cesarean after labor/planned cesarean
|
1 week after patient gives birth
|
|
Trial of labor after cesarean
Tijdsspanne: 1 week after the mother gives birth
|
Whether the woman was attempting a trial of labor after a previous cesarean birth
|
1 week after the mother gives birth
|
|
Vaginal birth after cesarean
Tijdsspanne: 1 week after patient gives birth
|
Whether the woman gave birth vaginally with this infant after she had a previous cesarean birth.
|
1 week after patient gives birth
|
|
Complications at birth
Tijdsspanne: 1 week after patient gives birth
|
The presence of any adverse outcomes during pregnancy, birth, postpartum, including details
|
1 week after patient gives birth
|
|
Breastfeeding at birth
Tijdsspanne: 1 week after patient gives birth
|
Breastmilk feeding of the infant at the time of birth
|
1 week after patient gives birth
|
|
Breastfeeding at discharge
Tijdsspanne: 1 week after patient gives birth
|
Breastmilk feeding of the infant at the time of discharge.
|
1 week after patient gives birth
|
|
Hospital stay postpartum
Tijdsspanne: 1 week after patient gives birth
|
Lengths of postpartum hospital stay in calendar days
|
1 week after patient gives birth
|
|
Generalized Anxiety Disorder 7-item scale (GAD-7)
Tijdsspanne: 2 weeks after intervention/comparison visit
|
Measure of anxiety level.
Scale can range from 0-21 with higher scores representing greater anxiety.
|
2 weeks after intervention/comparison visit
|
|
Generalized Anxiety Disorder 7-item scale (GAD-7)
Tijdsspanne: Within 2 weeks after patient gives birth
|
Measure of anxiety level.
Scale can range from 0-21 with higher scores representing greater anxiety.
|
Within 2 weeks after patient gives birth
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Julia Phillippi, PhD, Vanderbilt School of Nursing
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 160523
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Verloskunde
-
Karabuk UniversityVoltooid
-
Kahramanmaras Sutcu Imam UniversityInonu UniversityNog niet aan het werven
-
Kocaeli UniversityVoltooidPeer Mentorschap | MİDWİFERY STUDENT | Peer mentoring | Verloskundige opleidingKalkoen
Klinische onderzoeken op Collaborative Care
-
The Second Hospital of Shandong UniversityActief, niet wervend
-
Xuanwu Hospital, BeijingBioray LaboratoriesNog niet aan het wervenMultiple sclerose | Neuromyelitis Optica Spectrumstoornissen | Chronische inflammatoire demyeliniserende polyradiculoneuropathie | Myasthenia Gravis, gegeneraliseerdChina
-
The Second Hospital of Shandong UniversityActief, niet wervendVeiligheid en werkzaamheid van cellulaire geneesmiddelen, objectief responspercentage van proefpersonen, enzChina
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.WervingGeavanceerd hepatocellulair carcinoomChina
-
Nexcella Inc.Immix Biopharma, Inc.WervingLichte keten (AL) amyloïdoseVerenigde Staten
-
Second Affiliated Hospital, School of Medicine,...WervingRecidiverend en refractair B-cellymfoomChina
-
Southwest Hospital, ChinaOnbekendLymfoom, grote B-cel, diffuusChina
-
Peking University Third HospitalWervingRefractaire systemische lupus erythematosusChina
-
Technische Universität DresdenGerman Cancer Research CenterWervingNeoplasmata | Multipel myeloom bij terugval | Multipel myeloom, refractair | Recidiverend diffuus grootcellig B-cellymfoom (DLBCL) | Refractair diffuus grootcellig B-cellymfoom (DLBCL)Duitsland
-
Hangzhou Cheetah Cell Therapeutics Co., LtdBeëindigdVeiligheid en doeltreffendheidChina